Cuprizone neurotoxicity, copper deficiency and neurodegeneration

Neurotoxicology. 2010 Sep;31(5):509-17. doi: 10.1016/j.neuro.2010.05.008. Epub 2010 May 26.

Abstract

Cuprizone is used to obtain demyelination in mice. Cuprizone-treated mice show symptoms similar to several neurodegenerative disorders such as severe status spongiosus. Although it has a simple chemical formula, its neurotoxic mechanism is still unknown. In this work, we examined both physico-chemical properties and biological effects of cuprizone. Our results indicate that cuprizone has very complicated and misunderstood solution chemistry. Moreover, we show here the inability of cuprizone to cross neither the intestinal epithelial barrier nor the neuronal cell membrane, as well its high tolerability by cultured neurons. If added to mice diet, cuprizone does not accumulate in liver or in brain. Therefore, its neurotoxic effect is explainable only in terms of its capability to chelate copper, leading to chronic copper deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Membrane Permeability / drug effects
  • Cell Membrane Permeability / physiology
  • Ceruloplasmin / drug effects
  • Chemical Phenomena
  • Copper / deficiency*
  • Copper / metabolism
  • Cuprizone / chemistry
  • Cuprizone / toxicity*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Humans
  • Liver / metabolism
  • Mass Spectrometry / methods
  • Mice
  • Monoamine Oxidase Inhibitors / chemistry
  • Monoamine Oxidase Inhibitors / toxicity*
  • Nerve Degeneration / etiology*
  • Nerve Degeneration / metabolism
  • Neuroblastoma
  • Neurotoxicity Syndromes* / complications
  • Neurotoxicity Syndromes* / etiology
  • Neurotoxicity Syndromes* / metabolism
  • Oxidoreductases / metabolism
  • Spectrophotometry, Atomic / methods

Substances

  • Monoamine Oxidase Inhibitors
  • Cuprizone
  • Copper
  • Oxidoreductases
  • Ceruloplasmin